10 Leukemia Clinical Trials in Westwood, NJ (2026)

Q: How do I join a clinical trial in Westwood?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Westwood research site will contact you.

Recruiting Leukemia Studies in Westwood

NCT01804686Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolle...

Westwood, NJ700 participantsJanssen Research & Development, LLC

View Study Details

NCT05498428Recruiting

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

The purpose of this study is to assess the anti-tumor activity and safety of amivantamab which will be administered as a co-formulation with recombinant human hyaluronidase PH20 (rHuPH20) (subcutaneou...

Westwood, NJ520 participantsJanssen Research & Development, LLC

View Study Details

NCT05429632Recruiting

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

This is a multi-center, randomized, double-blinded, placebo controlled trial....

Westwood, NJ366 participantsPriothera SAS

View Study Details

NCT06859424Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

The purpose of this clinical trial is to compare drug combinations to learn which drugs work best to prevent graft-versus-host-disease (GVHD) in people who have received a stem cell transplant. The so...

Westwood, NJ358 participantsCenter for International Blood and Marrow Transplant Research

View Study Details

NCT04686305Recruiting

Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

DESTINY-Lung03 will investigate the safety and tolerability of trastuzumab deruxtecan in combination with Immunotherapy Agents with and without chemotherapy in patients with HER2 over-expressing non-s...

Westwood, NJ304 participantsAstraZeneca

View Study Details

NCT06697184Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

The purpose of this study is to establish the safety of novel dosing and ramp-up schedules for sonrotoclax in participants with hematological malignancies....

Westwood, NJ258 participantsBeiGene

View Study Details

NCT05882058Recruiting

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

This study is open to adults with small cell lung cancer and other neuroendocrine tumours. The study is in people with advanced cancer for whom previous treatment was not successful or no standard tre...

Westwood, NJ204 participantsBoehringer Ingelheim

View Study Details

NCT06218914Recruiting

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Phase I Study, a master protocol to investigate TCR-Engineered T cells recognizing KRAS mutations in adult subjects with Unresectable, Advanced, and/or Metastatic Solid Tumors....

Westwood, NJ108 participantsAstraZeneca

View Study Details

NCT03104491Recruiting

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

This study has two phases, Phase I and Phase II. The main goal of the Phase I portion of this research study is to see what doses post-transplant inotuzumab ozogamicin can safely be given to subjects ...

Westwood, NJ44 participantsLeland Metheny

View Study Details

NCT03533816Recruiting

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Gamma delta T-cells are part of the innate immune system with the ability to recognize malignant cells and kill them. This study uses gamma delta T-cells to maximize the anti-tumor response and minimi...

Westwood, NJ38 participantsUniversity of Kansas Medical Center

View Study Details

About Leukemia Clinical Trials in Westwood

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 10 leukemia clinical trials recruiting participants in Westwood, NJ. These studies are seeking a combined 2,900 participants. Research is being sponsored by Janssen Research & Development, LLC, Priothera SAS, Center for International Blood and Marrow Transplant Research and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Westwood — FAQ

Are there leukemia clinical trials in Westwood?

Yes, there are 10 leukemia clinical trials currently recruiting in Westwood, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Westwood?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Westwood research site will contact you about next steps.

Are clinical trials in Westwood free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Westwood studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 10 active trials in Westwood are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 13, 2026 from ClinicalTrials.gov